期刊
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 28, 期 18, 页码 3094-3098出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2018.07.037
关键词
Antisense technologies; Peptide nucleic acids; Antibiotics; Synergy
资金
- National Science Centre, Poland [SYMFONIA DEC-2014/12/W/ST5/00589, PRELUDIUM 2017/25/N/NZ1/01578]
- CeNT BST funds
- Ministry of Science and Higher Education [501-D313-86-0117000-02]
- Rotary International Youth Exchange Program [D. 4100 MX - D. 2231 PL]
A combination of antibacterial agents should make the emergence of resistance in bacteria less probable. Thus we have analyzed the synergistic effects between antibacterial antisense peptide nucleic acids (PNA) and conventional antibiotics against Escherichia coli. AS19 (lipopolysaccharide defective) strain and a derivative of a pathogenic strain E. coli. O157:H7. PNAs were designed to target mRNA transcripts encoding the essential acyl carrier protein (gene acpP) and conjugated to the cell-penetrating peptide (KFF)(3)K for cellular uptake. Antibiotics included aminoglycosides, aminopenicillins, polymyxins, rifamycins, sulfonamides and trimethoprim. Synergies were evaluated using the checkerboard technique. Fractional Inhibitory Concentration indices (FICi) were calculated for all combinations based on the minimal inhibitory concentration of each individual agent. The results demonstrate two novel synergistic combinations of antimicrobial agents, namely, (KFF)(3) K-PNA anti-acpP with polymyxin B and (KFF)(3)K-PNA anti-acpP with trimethoprim (both with FICi = 0.38). Polymyxin B's synergy postulates cell wall targeted antibiotics as attractive agents to improve the uptake of PNA while trimethoprim's interaction with PNA my reveal a new inhibitory mechanism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据